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Introduction
Pediatric patients with sickle cell disease (SCD) who
receive regular transfusions are at risk for developing car-
diac toxicity from iron overload. Although studies have
demonstrated risk factors for liver iron overload in these
patients, the correlation with cardiac iron deposition has
not been well established.
Purpose
To assess the correlation between myocardial iron deposi-
tion as assessed by T2* sensitive MRI and several func-
tional and biochemical measures in a pediatric SCD
population.
Methods
22 patients with SCD (Hb SS) at a steady state had T2*
sensitive cardiac MRI (1.5 T Avanto™, Siemens) from Jan-
uary 2009 to August 2009. All patients were receiving reg-
ular transfusion every 3-4 weeks and chelation therapy.
For each patient, a T2* value obtained from the interven-
tricular septum. Cardiac T2* values of > 25 ms were
recorded as normal, 20-25 ms as borderline and < 20 ms
as abnormal.
Results
Median myocardial T2* was 32.1 + 6.5 ms. Mean myocar-
dial T2* values were significantly lower than T2* values
measured in the paravertebral muscles in the same
patients (32.1 ± 6.5 versus 48.4 ± 5.2, p < 0.01). 1 patient
(5%) had an abnormal T2* value of 17 ms, while two
patients (9%) had borderline low values. Myocardial T2*
weakly negatively correlated with chronological age(r = -
0.46, p = 0.81). Although there was a strong correlation
between liver biopsy iron concentration and transfusion
burden (r = 0.63, p = 0.002) and ferritin (r = 0.72, p = <
0.001), transfusion burden was only weakly correlated
with cardiac T2* (r = -0.27, p = 0.29) and ferritin levels (r
= -0.42, p = 0.11). The left ventricular end-diastolic vol-
ume and ejection fraction showed a weak correlation with
T2* measurements (r = 0.17 and, r = 0.21 respectively).
Conclusion
Myocardial iron deposition cannot be predicted by liver
biopsy or indirect biochemical measures and therefore
cardiac MRI may be indicated for serial monitoring of
SCD patients.
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